These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3177963)
21. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response. Snyder PJ; Utiger RD J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417 [TBL] [Abstract][Full Text] [Related]
22. Juvenile thyrotoxicosis. Péter F Acta Endocrinol Suppl (Copenh); 1986; 279():361-6. PubMed ID: 3096041 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of serum TSH in euthyroid patients with paroxysmal atrial fibrillation. Kwon HM; Lee BK; Yoon YW; Seo JK; Kim HS Yonsei Med J; 1995 Nov; 36(5):448-56. PubMed ID: 8546003 [TBL] [Abstract][Full Text] [Related]
24. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation. Szabolcs I; Ploenes C; Bernard W; Herrmann J Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111 [TBL] [Abstract][Full Text] [Related]
25. Audit of hyperthyroxinaemia and thyrotoxicosis using a sensitive TSH assay. O'Hare J; Abuaisha B; Barrett E Ir Med J; 1991 Jun; 84(2):70-2. PubMed ID: 1910022 [TBL] [Abstract][Full Text] [Related]
26. Adverse cardiovascular responses to thyrotropin-releasing hormone (200 micrograms) in cardiac patients. Sobel RJ; Ariad S Isr J Med Sci; 1987 Nov; 23(11):1107-9. PubMed ID: 3125128 [TBL] [Abstract][Full Text] [Related]
27. Subclinical thyrotoxicosis. Sengupta N; Maji D J Indian Med Assoc; 2006 Oct; 104(10):596, 598-600. PubMed ID: 17380827 [TBL] [Abstract][Full Text] [Related]
28. Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED. Buccelletti F; Carroccia A; Marsiliani D; Gilardi E; Silveri NG; Franceschi F Am J Emerg Med; 2011 Nov; 29(9):1158-62. PubMed ID: 20708873 [TBL] [Abstract][Full Text] [Related]
29. Thyroid function in patients in clinical remission after medical treatment of thyrotoxicosis. Hooper MJ; Ratcliffe JG; Ratcliffe WA; Spencer CA; McLarty DG; Alexander WD J Clin Endocrinol Metab; 1975 May; 40(5):807-11. PubMed ID: 47864 [TBL] [Abstract][Full Text] [Related]
30. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression. Sarne DH; Sobieszczyk S; Ain KB; Refetoff S J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573 [TBL] [Abstract][Full Text] [Related]
31. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy. Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309 [TBL] [Abstract][Full Text] [Related]
32. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone. Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119 [TBL] [Abstract][Full Text] [Related]
33. [Diminution of thyroid stimulating hormone level but normal levels of thyroid hormones. Demonstration of occult hyperthyroidism]. Schlienger JL; Klerlein M; Sapin R; Demangeat JL; Imler M Presse Med; 1989 Apr; 18(14):707-10. PubMed ID: 2471184 [TBL] [Abstract][Full Text] [Related]